drugset / Trial / NCT00564018

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

NCT00564018

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether using a long-acting insulin analog at the time of diagnosis, instead of intermediate-acting insulin, affects the rate of loss of the body's ability to make insulin in children with newly diagnosed type 1 diabetes.

Timeline

Start
2006-09
Primary completion
2009-02
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject NPH Protein / enzyme biologic
Subject insulin detemir Protein / enzyme biologic
Subject insulin glargine Protein / enzyme biologic